Proteomics of inflammatory and oxidative stress response in cows with subclinical and clinical mastitis

Journal of Proteomics

Volumn 75, Issue 14, 2012, Pages 4412-4428

  Turk, Romana ^a   Piras, Cristian ^b   Kovačić, Mislav ^c   Samardžija, Marko ^a   Ahmed, Hany ^d   De Canio, Michele ^e   Urbani, Andrea ^e,f   Meštrić, Zlata Flegar ^g   Soggiu, Alessio ^d   Bonizzi, Luigi ^d   Roncada, Paola ^d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b UNIVERSITY OF SASSARI   (Italy)

^c PharmaS doo ^*  (Croatia)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^g University of Zagreb   (Croatia)

Author keywords

Cows; Inflammation; Mastitis; Oxidative stress; Proteomics

Indexed keywords

AMYLOID A PROTEIN; APOLIPOPROTEIN A1; CALCIUM; COMPLEMENT COMPONENT C4B BINDING PROTEIN; COMPLEMENT FACTOR H; HAPTOGLOBIN; INTER ALPHA TRYPSIN INHIBITOR; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN H4; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; VITRONECTIN;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM BLOOD LEVEL; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; COW; MASTITIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; CATTLE; CATTLE DISEASES; FEMALE; MASTITIS; OXIDATIVE STRESS; PROTEOME; REACTIVE OXYGEN SPECIES; VITRONECTIN;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 84863819823     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.05.021     Document Type: Article

References (92)

1. Seegers H., Fourichon C., Beaudeau F. Production effects related to mastitis and mastitis economics in dairy cattle herds. Vet Res 2003, 34:475-491.
2. Santos J.E., Cerri R.L., Ballou M.A., Higginbotham G.E., Kirk J.H. Effect of timing of first clinical mastitis occurrence on lactational and reproductive performance of Holstein dairy cows. Anim Reprod Sci 2004, 80:31-45.
3. Viguier C., Arora S., Gilmartin N., Welbeck K., O'Kennedy R. Mastitis detection: current trends and future perspectives. Trends Biotechnol 2009, 27:486-493.
4. Hill A.W., Finch J.M., Field T.R., Leigh J.A. Immune modification of the pathogenesis of Streptococcus uberis mastitis in the dairy cow. FEMS Immunol Med Microbiol 1994, 8:109-117.
5. Eckersall P.D., Young F.J., Nolan A.M., Knight C.H., McComb C., Waterston M.M., et al. Acute phase proteins in bovine milk in an experimental model of Staphylococcus aureus subclinical mastitis. J Dairy Sci 2006, 89:1488-1501.
6. Vels L., Rontved C.M., Bjerring M., Ingvartsen K.L. Cytokine and acute phase protein gene expression in repeated liver biopsies of dairy cows with a lipopolysaccharide-induced mastitis. J Dairy Sci 2009, 92:922-934.
7. Eckersall P.D. Acute phase proteins: from research laboratory to clinic. Vet Clin Pathol 2010, 39:1-2.
8. Gruys E., Toussaint M., Niewold T., Koopmans S. Review: acute phase reaction and acute phase proteins. J Zhejiang Univ Sci B 2005, 6:1045.
9. Higai K., Azuma Y., Aoki Y., Matsumoto K. Altered glycosylation of [alpha] 1-acid glycoprotein in patients with inflammation and diabetes mellitus. Clin Chim Acta 2003, 329:117-125.
10. Andersson M., Sevelius E. Abnormal microheterogeneity of haptoglobin in serum from dogs with various diseases. Vet Rec 2001, 148:14.
11. Eckersall P., Bell R. Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine. Vet J 2010, 185:23-27.
12. Danielsen M., Codrea M.C., Ingvartsen K.L., Friggens N.C., Bendixen E., Røntved C.M. Quantitative milk proteomics-host responses to lipopolysaccharide-mediated inflammation of bovine mammary gland. Proteomics 2010, 10:2240-2249.
13. Boehmer J.L., DeGrasse J.A., McFarland M.A., Tall E.A., Shefcheck K.J., Ward J.L., et al. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis. Vet Immunol Immunopathol 2010, 138:252-266.
14. Smolenski G., Haines S., Fiona Y.S.K., Bond J., Farr V., Davis S.R., et al. Characterisation of host defence proteins in milk using a proteomic approach. J Proteome Res 2007, 6:207-215.
15. Thannickal V.J., Fanburg B.L. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000, 279:L1005-L1028.
16. Halliwell B. Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem Soc Trans 1996, 24:1023-1027.
17. Halliwell B. Vitamin C: antioxidant or pro-oxidant in vivo?. Free Radic Res 1996, 25:439-454.
18. Halliwell B. Antioxidants in human health and disease. Annu Rev Nutr 1996, 16:33-50.
19. Halliwell B. Mechanisms involved in the generation of free radicals. Pathol Biol (Paris) 1996, 44:6-13.
20. Nordberg J., Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001, 31:1287-1312.
21. Sordillo L.M., Aitken S.L. Impact of oxidative stress on the health and immune function of dairy cattle. Vet Immunol Immunopathol 2009, 128:104-109.
22. Miller J.K., Brzezinska-Slebodzinska E., Madsen F.C. Oxidative stress, antioxidants, and animal function. J Dairy Sci 1993, 76:2812-2823.
23. Maddox J.F., Aherne K.M., Reddy C.C., Sordillo L.M. Increased neutrophil adherence and adhesion molecule mRNA expression in endothelial cells during selenium deficiency. J Leukoc Biol 1999, 65:658-664.
24. Grasso P.J., Scholz R.W., Erskine R.J., Eberhart R.J. Phagocytosis, bactericidal activity, and oxidative metabolism of milk neutrophils from dairy cows fed selenium-supplemented and selenium-deficient diets. Am J Vet Res 1990, 51:269-274.
25. Hogan J.S., Smith K.L., Weiss W.P., Todhunter D.A., Schockey W.L. Relationships among vitamin E, selenium, and bovine blood neutrophils. J Dairy Sci 1990, 73:2372-2378.
26. Hogan J.S., Weiss W.P., Todhunter D.A., Smith K.L., Schoenberger P.S. Bovine neutrophil responses to parenteral vitamin E. J Dairy Sci 1992, 75:399-405.
27. Cao Y.Z., Cohen Z.S., Weaver J.A., Sordillo L.M. Selenium modulates 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) biosynthesis in bovine aortic endothelial cells. Antioxid Redox Signal 2001, 3:1147-1152.
28. Stafforini D.M., McIntyre T.M., Carter M.E., Prescott S.M. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem 1987, 262:4215-4222.
29. Stafforini D.M., Prescott S.M., McIntyre T.M. Human plasma platelet-activating factor acetylhydrolase. Purification and properties. J Biol Chem 1987, 262:4223-4230.
30. Isogai E., Hirose K., Kimura K., Hayashi S., Kubota T., Fujii N., et al. Role of platelet-activating-factor (PAF) on cellular responses after stimulation with leptospire lipopolysaccharide. Microbiol Immunol 1997, 41:271-275.
31. Stafforini D.M., Numao T., Tsodikov A., Vaitkus D., Fukuda T., Watanabe N., et al. Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthma. J Clin Invest 1999, 103:989-997.
32. Stafforini D.M., Tjoelker L.W., McCormick S.P., Vaitkus D., McIntyre T.M., Gray P.W., et al. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J Biol Chem 1999, 274:7018-7024.
33. Stafforini D.M., Tjoelker L.W. Human plasma platelet-activating factor acetylhydrolase. Methods Mol Biol 1999, 109:49-58.
34. Stafforini D.M., McIntyre T.M., Zimmerman G.A., Prescott S.M. Platelet-activating factor acetylhydrolases. J Biol Chem 1997, 272:17895-17898.
35. Boehmer J.L. Proteomic analyses of host and pathogen responses during bovine mastitis. J Mammary Gland Biol Neoplasia 2011, 1-16.
36. O'Donnell R., Holland J., Deeth H., Alewood P. Milk proteomics. Int Dairy J 2004, 14:1013-1023.
37. Alonso-Fauste I., Andrés M., Iturralde M., Lampreave F., Gallart J., Álava M.A. Proteomic characterization by 2-DE in bovine serum and whey from healthy and mastitis affected farm animals. J Proteomics 2012, 75:3015-3030.
38. Baeker R., Haebel S., Schlatterer K., Schlatterer B. Lipocalin-type prostaglandin D synthase in milk: a new biomarker for bovine mastitis. Prostaglandins Other Lipid Mediat 2002, 67:75-88.
39. Eckersall P., Young F., McComb C., Hogarth C., Safi S., Fitzpatrick J., et al. Acute phase proteins in serum and milk from dairy cows with clinical mastitis. Vet Rec 2001, 148:35-41.
40. Eckersall P., Young F., Nolan A., Knight C., McComb C., Waterston M., et al. Acute phase proteins in bovine milk in an experimental model of Staphylococcus aureus subclinical mastitis. J Dairy Sci 2006, 89:1488-1501.
41. Pieragostino D., Petrucci F., Del Boccio P., Mantini D., Lugaresi A., Tiberio S., et al. Pre-analytical factors in clinical proteomics investigations: Impact of ex vivo protein modifications for multiple sclerosis biomarker discovery. J Proteomics 2010, 73:579-592.
42. Mackness M.I., Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 1995, 115:243-253.
43. Mackness M.I., Harty D., Bhatnagar D., Winocour P.H., Arrol S., Ishola M., et al. Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. Atherosclerosis 1991, 86:193-199.
44. Schiavon R., De Fanti E., Giavarina D., Biasioli S., Cavalcanti G., Guidi G. Serum paraoxonase activity is decreased in uremic patients. Clin Chim Acta 1996, 247:71-80.
45. Kosaka T., Yamaguchi M., Soda Y., Kishimoto T., Tago A., Toyosato M., et al. Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity. Clin Chim Acta 2000, 296:151-161.
46. Della Donna L., Ronci M., Sacchetta P., Di Ilio C., Biolatti B., Federici G., et al. A food safety control low mass-range proteomics platform for the detection of illicit treatments in veal calves by MALDI-TOF-MS serum profiling. Biotechnol J 2009, 4:1596-1609.
47. Roncada P., Begni B., Amadori M., Cristoni S., Archetti I., Boldetti C., et al. Blood serum proteome for welfare evaluation in pigs. Vet Res Commun 2007, 31:321-325.
48. Minota S., Winfield J.B. Identification of three major target molecules of IgM antilymphocyte autoantibodies in systemic lupus erythematosus. J Immunol 1987, 139:3644.
49. Ishihama Y., Oda Y., Tabata T., Sato T., Nagasu T., Rappsilber J., et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005, 4:1265-1272.
50. Pieragostino D., Petrucci F., Del Boccio P., Mantini D., Lugaresi A., Tiberio S., et al. Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery. J Proteomics 2010, 73:579-592.
51. D'Alessandro A., D'Aguanno S., Cencioni M.T., Pieroni L., Diamantini A., Battistini L., et al. Protein repertoire impact of ubiquitin-proteasome system impairment: insight into the protective role of beta-estradiol. J Proteomics 2012 Feb 2, 75(4):1440-1453.
52. Grummer R.R., Meacham C.A., Hurley W.L., Davis C.L. Apolipoprotein composition of bovine lipoproteins isolated by gel filtration chromatography. Comp Biochem Physiol B Comp Biochem 1987, 88:1163-1174.
53. Eckersall P.D., Young F.J., McComb C., Hogarth C.J., Safi S., Weber A., et al. Acute phase proteins in serum and milk from dairy cows with clinical mastitis. Vet Rec 2001, 148:35-41.
54. Van Lenten B., Hama S., De Beer F., Stafforini D., McIntyre T., Prescott S., et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995, 96:2758.
55. Ranjan R., Swarup D., Naresh R., Patra R.C. Enhanced erythrocytic lipid peroxides and reduced plasma ascorbic acid, and alteration in blood trace elements level in dairy cows with mastitis. Vet Res Commun 2005, 29:27-34.
56. Atakisi O., Oral H., Atakisi E., Merhan O., Metin Pancarci S., Ozcan A., et al. Subclinical mastitis causes alterations in nitric oxide, total oxidant and antioxidant capacity in cow milk. Res Vet Sci 2010, 89:10-13.
57. Turk R., Juretic D., Geres D., Turk N., Rekic B., Simeon-Rudolf V., et al. Serum paraoxonase activity in dairy cows during pregnancy. Res Vet Sci 2005, 79:15-18.
58. Turk R., Juretic D., Geres D., Turk N., Rekic B., Simeon-Rudolf V., et al. Serum paraoxonase activity and lipid parameters in the early postpartum period of dairy cows. Res Vet Sci 2004, 76:57-61.
59. Cabana V., Siegel J., Sabesin S. Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. J Lipid Res 1989, 30:39-49.
60. Cabana V., Lukens J., Rice K.S., Hawkins T.J., Getz G. HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease. J Lipid Res 1996, 37:2662.
61. -/- mice. J Lipid Res 1999, 40:1090-1103.
62. Ceciliani F, Ceron J, Eckersall P, Sauerwein H. Acute phase proteins in ruminants. J Proteomics in press, http://dx.doi.org/10.1016/j.jprot.2012.04.004.
63. Ribas V., Sánchez-Quesada J.L., Antón R., Camacho M., Julve J., Vila L., et al. Human apolipoprotein a-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties. Circ Res 2004, 95:789-797.
64. Watanabe J., Charles-Schoeman C., Miao Y., Elashoff D., Lee Y.Y., Katselis G., et al. Proteomic profiling following immunoaffinity capture of HDL: association of acute phase proteins and complement factors with pro-inflammatory HDL in rheumatoid arthritis. Arthritis Rheum 2012, 64:1828-1837.
65. Vaisar T., Pennathur S., Green P.S., Gharib S.A., Hoofnagle A.N., Cheung M.C., et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J Clin Invest 2007, 117:746.
66. Seth M., Lamont E.A., Janagama H.K., Widdel A., Vulchanova L., Stabel J.R., et al. Biomarker discovery in subclinical mycobacterial infections of cattle. PLoS One 2009, 4:e5478.
67. Hwang S.R., Steineckert B., Yasothornsrikul S., Sei C.A., Toneff T., Rattan J., et al. Molecular cloning of endopin 1, a novel serpin localized to neurosecretory vesicles of chromaffin cells. J Biol Chem 1999, 274:34164-34173.
68. Tassy C., Herrera-Mendez C.H., Sentandreu M.A., Aubry L., Brémaud L., Pélissier P., et al. Muscle endopin 1, a muscle intracellular serpin which strongly inhibits elastase: purification, characterization, cellular localization and tissue distribution. Biochem J 2005, 388:273.
69. Rodríguez de Córdoba S., Esparza-Gordillo J., Goicoechea de Jorge E., Lopez-Trascasa M., Sánchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 2004, 41:355-367.
70. Filippsen L., Valentin-Weigand P., Blobel H., Preissner K., Chhatwal G. Role of complement S protein (vitronectin) in adherence of Streptococcus dysgalactiae to bovine epithelial cells. Am J Vet Res 1990, 51:861.
71. Preissner K.T., Heimburger N., Anders E., Muller-Berghaus G. Physicochemical, immunochemical and functional comparison of human S-protein and vitronectin evidence for the identity of both plasma proteins. Biochem Biophys Res Commun 1986, 134:951-956.
72. Kolb W.P., Muller-Eberhard H.J. The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex. J Exp Med 1975, 141:724.
73. Underwood P.A., Kirkpatrick A., Mitchell S.M. New insights into heparin binding to vitronectin: studies with monoclonal antibodies. Biochem J 2002, 365:57.
74. Barnes D., Wolfe R., Serrero G., McClure D., Sato G. Effects of a serum spreading factor on growth and morphology of cells in serum-free medium. J Supramol Struct 1980, 14:47-63.
75. Virji M. Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat Rev Microbiol 2009, 7:274-286.
76. Bergmann S., Lang A., Rohde M., Agarwal V., Rennemeier C., Grashoff C., et al. Integrin-linked kinase is required for vitronectin-mediated internalization of Streptococcus pneumoniae by host cells. J Cell Sci 2009, 122:256-267.
77. Pineiro M., Andres M., Iturralde M., Carmona S., Hirvonen J., Pyorala S., et al. ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4) is a new acute-phase protein isolated from cattle during experimental infection. Infect Immun 2004, 72:3777.
78. Salonen M., Hirvonen J., Pyörälä S., Sankari S., Sandholm M. Quantitative determination of bovine serum haptoglobin in experimentally induced Escherichia coli mastitis. Res Vet Sci 1996, 60:88-91.
79. Katoh N., Nakagawa H. Detection of haptoglobin in the high-density lipoprotein and the very high-density lipoprotein fractions from sera of calves with experimental pneumonia and cows with naturally occurring fatty liver. J Vet Med Sci 1999, 61:119.
80. Yerbury J.J., Rybchyn M.S., Easterbrook-Smith S.B., Henriques C., Wilson M.R. The acute phase protein haptoglobin is a mammalian extracellular chaperone with an action similar to clusterin. Biochemistry 2005, 44:10914-10925.
81. Santucci L., Candiano G., Petretto A., Pavone B., Bruschi M., Gusmano R., et al. Protein-protein interaction heterogeneity of plasma apolipoprotein A1 in nephrotic syndrome. Mol Biosyst 2011, 7:659-666.
82. Salvatore A., Cigliano L., Bucci E.M., Corpillo D., Velasco S., Carlucci A., et al. Haptoglobin binding to apolipoprotein AI prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase. Biochemistry 2007, 46:11158-11168.
83. Yunee K., Heba A., Bonnie M., Claude R., Niel K. Changes in Holstein cow milk and serum proteins during intramammary infection with three different strains of Staphylococcus aureus. BMC Vet Res 2011, 7:51. 10.1186/1746-6148-7-51.
84. Jonas A. Isolation and partial characterization of the major apolipoprotein component of bovine serum high density lipoprotein. Biochimica et Biophysica Acta (BBA)-Protein. Structure 1975, 393:460-470.
85. Cordle S., Clegg R., Yeaman S. Purification and characterization of bovine lipoproteins: resolution of high density and low density lipoproteins using heparin-sepharose chromatography. J Lipid Res 1985, 26:721.
86. Liao X., Lou B., Ma J., Wu M. Neutrophils activation can be diminished by apolipoprotein AI. Life Sci 2005, 77:325-335.
87. Yan Y., Li Y., Lou B., Wu M. Beneficial effects of ApoA-I on LPS-induced acute lung injury and endotoxemia in mice. Life Sci 2006, 79:210-215.
88. Burger D., Dayer J.M. High-density lipoprotein-associated apolipoprotein AI: the missing link between infection and chronic inflammation?. Autoimmun Rev 2002, 1:111-117.
89. Cabana V., Lukens J., Rice K.S., Hawkins T.J., Getz G. HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease. J Lipid Res 1996, 37:2662-2674.
90. Han C.Y., Chiba T., Campbell J.S., Fausto N., Chaisson M., Orasanu G., et al. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein AI and paraoxonase-1 by inflammation in murine hepatocytes. Arterioscler Thromb Vasc Biol 2006, 26:1806-1813.
91. Hassett C., Richter R.J., Humbert R., Chapline C., Crabb J.W., Omiecinski C.J., et al. Characterization of cDNA clones encoding rabbit and human serum paraoxonase: the mature protein retains its signal sequence. Biochemistry 1991, 30:10141-10149.
92. Watanabe J., Grijalva V., Hama S., Barbour K., Berger F.G., Navab M., et al. Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein. J Biol Chem 2009, 284:18292.